OncoMed Pharmaceuticals, Inc. is a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. As of 2013, the company had 83 employees. OncoMed's drug discovery work focuses on developing "targeted antibodies against cancer stem cells". The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company. OncoMed went public in 2013 and is listed on NASDAQ under the stock symbol OMED.
|Key people||Paul Hastings (CEO) John Lewicki (R&D chief) Chuck Alaimo (Operations director)|
|Founded||University of Michigan August 2004; 12 years ago (2004-08)|
|Headquarters||Redwood City, California, United States|
|Founders||Michael Clarke Max Wicha|
|Total assets||US$207,600,000 (2016)|
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Yes, it is.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If OncoMed Pharmaceuticals, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of OncoMed Pharmaceuticals, Inc. with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|3 Mobile||Telecommunications / Wireless Carrier||16|
|Morgan Stanley||Financial Services / Banking||16|
|Sainsburys||Consumer Brands / Grocery||16|
|FlexiGroup||Financial Services / Banking||15|
|HBO||Consumer Brands / Entertainment||15|
|PNC Banks||Financial Services / Banking||15|
|AT&T||Telecommunications / Cable/TV service||15|
|Sprite||Consumer Brands / FMCG||17|
|TSB Bank||Financial Services / Banking||17|
|Starz||Consumer Brands / Entertainment||17|
We have estimated the Net Promoter Score of OncoMed Pharmaceuticals, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.